Mosaad Megahed

Mosaad Megahed
Born (1956-12-10) December 10, 1956
Alexandria
Residence Germany
Nationality German
Fields skin and genital diseases as well as dermatohistology
Institutions University Hospital Aachen
Known for general dermatology, dermatopathology, autoimmune and hereditary blistering diseases
Notable awards K.G. Steigleder-Prize

Mosaad Megahed (born December 10, 1956 in Alexandria, Egypt) is a German specialist in skin and genital diseases as well as dermatohistology. He is professor and senior physician at the Clinic for Dermatology and Allergology of the University Hospital Aachen. His main focus areas are general dermatology, dermatopathology, autoimmune and hereditary blistering diseases, skin cancer as well as immunological inflammatory skin diseases like atopic dermatitis, collagen diseases, vitiligo and urticaria.

Biography

After Megahed had finished his studies in medicine, he was a resident in the department of Dermatology and Allergology at the University Hospital of the University of Düsseldorf with Gerd Plewig. In 1990 he was recognized as a specialist in skin and genital diseases and one year later he received the additional title allergology. In 1991 Megahed went to the University of Glasgow to join the research team of Rona MacKie. He returned to the University Dermatologic Hospital Düsseldorf as senior physician in the same year. In 1994 he achieved his doctorate in medicine. From 1994 until 1996 Megahed had been completing a research stay at the Thomas Jefferson University in Philadelphia with Jouni Uitto. During that time, he also continued his training in dermatohistology with Bernie Ackerman at the same university. In 1996 he habilitated and received the teaching license at the University of Düsseldorf, where he has been working as professor and senior physician until 2005. In 2005 Megahed changed to the University RWTH Aachen, where he has been professor and senior physician until today.[1] Since 2006, Megahed has the additional title Dermahistology. He also is working as an examiner at the Medical Association North Rhine-Westphalia.[2]

Scientific contribution

Awards

In 2003 Megahed and his colleagues received the K.G. Steigleder-Price for the best work on dermahistology by the working group Dermatological Histology (ADH).[15]

Memberships in scientific organizations

Megahed is a member of the German Dermatological Society, German Research Foundation and German Working Group for Dermatohistology, and the European Society of Dermatopathology.[16]

Publications

Books

Articles

Megahed published more than 280 articles in scientific journals (April 2016).

References

  1. University Hospital Aachen, functional areas
  2. CV of Mosaad Megahed (German)
  3. MyBioSource Ladinin
  4. U42408 GenBank
  5. O00515 NCBI
  6. U58994 GenBank
  7. U58011 GenBank
  8. M. Megahed, M. Schon, D. Selimovic, M. P. Schön: Reliability of diagnosis of melanoma in situ. In: Lancet. 359, 2002, S. 1921–1922.
  9. M. Megahed: Histopathology of Blistering Diseases - With Clinical, Electron Microscopic, Immunological and Molecular Biological Correlations Textbook and Atlas. Springer Verlag, Berlin/ Heidelberg 2004 , ISBN 3-540-42562-4.
  10. C. Schuetz, K. Huck, S. Gudowius, M. Megahed, O. Feyen, B. Hubner, D. T. Schneider, B. Manfras, U. Pannicke, R. Willemze, R. Knüchel, U. Göbel, A. Schulz, A. Borkhardt, W. Friedrich, K. Schwarz, T. Niehues: An Immunodeficiency Disease with RAG Mutations and Granulomas. In: New England Journal of Medicine. 358, 2008, S. 2030–2038.
  11. B. Voss, S. Wilop, S. Jonas, M. H. M. El-Komy, J. Schaller, V. von Felbert, M. Megahed: Tumor Volume as a Prognostic Factor in Resectable Malignant Melanoma. In: Dermatology. 228, 2014, S. 66–70.
  12. A. El-Khattouti, D. Selimovic, M. Hannig, E. B. Taylor, Z. Y. Abd-Elmageed, S. Y. Hassan, Y. Haikel, E. Kandil, M. Leverkus, R. T. Brodell, M. Megahed, M. Hassan: Imiquimod-induced apoptosis of melanoma cells is mediated by ER stress-dependent Noxa induction and enhanced by NF-κB inhibition. In: J Cell Mol Med. 20, 2016, S. 266–286.
  13. M. Hassan, D. Selimovic, M. Hannig, Y. Haikel, R. T. Brodell, M. Megahed: Endoplasmic reticulum stress-mediated pathways to both apoptosis and autophagy: Significance for melanoma treatment. In: World J Exp Med. 5(4), 20. Nov 2015, S. 206–217.
  14. A. El-Khattouti, N. Sheehan, J. Monico, H. A. Drummond, Y. Haikel, R. T. Brodell, M. Megahed, M. Hassan: CD133+ melanoma subpopulation acquired resistance to caffeic acid phenethyl ester-induced apoptosis is attributed to the elevated expression of ABCB5: Significance for melanoma treatment. In: . Cancer Lett. 357, 2015, S. 83–104.
  15. K.G. Steigleder-Price for M. Megahed
  16. European Society of Dermatopathology
This article is issued from Wikipedia - version of the 9/9/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.